Skip to main content
Erschienen in: Drugs in R&D 1/2008

01.01.2008 | Original Research Article

Efficacy of a Mucoadhesive Patch Compared with an Oral Solution for Treatment of Aphthous Stomatitis

verfasst von: Avner Shemer, Boaz Amichai, Henri Trau, Nir Nathansohn, Boaz Mizrahi, Prof. Abraham J. Domb

Erschienen in: Drugs in R&D | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective: The purpose of this study was to evaluate the efficacy and tolerability of a mucoadhesive patch compared with a pain-relieving oral solution for the treatment of aphthous stomatitis.
Methods: Patients with active aphthous stomatitis were randomly treated either once a day with a mucoadhesive patch containing citrus oil and magnesium salts (n = 26) or three times a day with an oral solution containing benzocaine and compound benzoin tincture (n = 22). All patients were instructed to apply the medication until pain had resolved, and completed a questionnaire detailing multiple clinical parameters followed by an evaluation of the treatment.
Results: The mucoadhesive patch was found to be more effective than the oral solution in terms of healing time (mean ± SD: 36.0 ± 22.8 hours vs 134.7 ± 57.7, p < 0.001) and pain intensity after 12 and 24 hours (3.7 ± 2.8 vs 6.3 ± 2.6, p = 0.003, and 2.3 ± 2.7 vs 5.7 ± 2.5, p < 0.001, respectively). Local adverse effects 1 hour after treatment were significantly (p < 0.01) less frequent among the mucoadhesive patch patients compared with the oral solution patients.
Conclusions: The mucoadhesive patch was found to be significantly more effective and better tolerated than the oral solution in the treatment of aphthous stomatitis.
Fußnoten
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literatur
1.
2.
Zurück zum Zitat Stone OJ. Aphthous stomatitis (canker sores): a consequence of high oral submucosal viscosity (the role of extracellular-matrix and the possible role of lectins). Med Hypotheses 1991; 36 (4): 341–4CrossRef Stone OJ. Aphthous stomatitis (canker sores): a consequence of high oral submucosal viscosity (the role of extracellular-matrix and the possible role of lectins). Med Hypotheses 1991; 36 (4): 341–4CrossRef
3.
Zurück zum Zitat Zunt SL. Recurrent aphthous stomatitis. Dermatol Clin 2003 Jan; 21 (1): 33–39CrossRef Zunt SL. Recurrent aphthous stomatitis. Dermatol Clin 2003 Jan; 21 (1): 33–39CrossRef
4.
Zurück zum Zitat Woodley J. Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet 2001; 40 (2): 77–84CrossRef Woodley J. Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet 2001; 40 (2): 77–84CrossRef
5.
Zurück zum Zitat Plemons JM, Rees TD, Binnie WH, et al. Evaluation of acemannan in the treatment of recurrent aphthous stomatitis. Wounds 1994; 6: 40–5 Plemons JM, Rees TD, Binnie WH, et al. Evaluation of acemannan in the treatment of recurrent aphthous stomatitis. Wounds 1994; 6: 40–5
6.
Zurück zum Zitat Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int 2000; 31 (2): 95–112PubMed Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int 2000; 31 (2): 95–112PubMed
7.
Zurück zum Zitat Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis: literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992; 74: 79–86CrossRef Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis: literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992; 74: 79–86CrossRef
8.
Zurück zum Zitat Pedersen A. Psychologic stress and recurrent aphthous ulceration. J Oral Pathol Med 1989; 18 (2): 119–22CrossRef Pedersen A. Psychologic stress and recurrent aphthous ulceration. J Oral Pathol Med 1989; 18 (2): 119–22CrossRef
9.
Zurück zum Zitat Nolan A, Lamey PJ, Milligan KA, et al. Recurrent aphthous ulceration and food sensitivity. J Oral Pathol Med 1991; 20 (10): 473–5CrossRef Nolan A, Lamey PJ, Milligan KA, et al. Recurrent aphthous ulceration and food sensitivity. J Oral Pathol Med 1991; 20 (10): 473–5CrossRef
10.
Zurück zum Zitat Brokstad B, Barkvoll P. The effect of two toothpaste detergents on the frequency of recurrent aphthous ulcers. Acta Odontol Scand 1996; 54 (3): 150–3CrossRef Brokstad B, Barkvoll P. The effect of two toothpaste detergents on the frequency of recurrent aphthous ulcers. Acta Odontol Scand 1996; 54 (3): 150–3CrossRef
11.
Zurück zum Zitat Natah SS, Hayrinen-Immonen R, Hietanen J, et al. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU). J Oral Pathol Med 2000; 29 (1): 19–25CrossRef Natah SS, Hayrinen-Immonen R, Hietanen J, et al. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU). J Oral Pathol Med 2000; 29 (1): 19–25CrossRef
12.
Zurück zum Zitat Porter SR, Hegarty A, Kaliakatsou F, et al. Recurrent aphthous stomatitis. Clin Dermatol 2000; 18 (5): 569–78CrossRef Porter SR, Hegarty A, Kaliakatsou F, et al. Recurrent aphthous stomatitis. Clin Dermatol 2000; 18 (5): 569–78CrossRef
13.
Zurück zum Zitat Khandwala A, VanInwegen RG, Alfano MC. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: 1. Clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83 (2): 222–30CrossRef Khandwala A, VanInwegen RG, Alfano MC. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: 1. Clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83 (2): 222–30CrossRef
14.
Zurück zum Zitat Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Delivery Rev 1993; 11 (1–2): 179–91CrossRef Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Delivery Rev 1993; 11 (1–2): 179–91CrossRef
15.
Zurück zum Zitat Shojaei AH, Paulson J, Honary S. Evaluation of poly(acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuc-cal drug delivery: factors affecting the force of mucoadhesion. J Control Release 2000; 67 (2–3): 223–32CrossRef Shojaei AH, Paulson J, Honary S. Evaluation of poly(acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuc-cal drug delivery: factors affecting the force of mucoadhesion. J Control Release 2000; 67 (2–3): 223–32CrossRef
16.
Zurück zum Zitat Mizrahi B, Golenser J, Wolnerman JS, et al. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci 2004; 93 (12): 2927–35CrossRef Mizrahi B, Golenser J, Wolnerman JS, et al. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci 2004; 93 (12): 2927–35CrossRef
17.
Zurück zum Zitat Mizrahi B, Shapira L, Domb AJ, et al. Citrus oil and MgCl2 as antibacterial and anti-inflammatory agents. J Periodont 2006; 77 (6): 963–8CrossRef Mizrahi B, Shapira L, Domb AJ, et al. Citrus oil and MgCl2 as antibacterial and anti-inflammatory agents. J Periodont 2006; 77 (6): 963–8CrossRef
18.
Zurück zum Zitat Houri-Haddad Y, Soskolne WA, Halabi A, et al. Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology 2000; 99 (2): 215–20CrossRef Houri-Haddad Y, Soskolne WA, Halabi A, et al. Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology 2000; 99 (2): 215–20CrossRef
19.
Zurück zum Zitat Cianciola JA, Algieri ML, Bush P, et al. Duration and intensity of anesthetic effect produced by Canker Sore Medications. J Clin Dentistry 1997; 8 (4): 100–2 Cianciola JA, Algieri ML, Bush P, et al. Duration and intensity of anesthetic effect produced by Canker Sore Medications. J Clin Dentistry 1997; 8 (4): 100–2
20.
Zurück zum Zitat Nagai T, Machida Y. Advances in drug delivery: mucosal adhesive dosage forms. Pharm Internat 1985; 8: 196–200 Nagai T, Machida Y. Advances in drug delivery: mucosal adhesive dosage forms. Pharm Internat 1985; 8: 196–200
21.
Zurück zum Zitat Kutcher MJ, Ludlow JB, Samuelson AD, et al. Evaluation of a bioadhesive device for the management of aphthous ulcers. J Am Dent Assoc 2001; 132 (3): 368–76CrossRef Kutcher MJ, Ludlow JB, Samuelson AD, et al. Evaluation of a bioadhesive device for the management of aphthous ulcers. J Am Dent Assoc 2001; 132 (3): 368–76CrossRef
22.
Zurück zum Zitat Bravo-Osuna I, Vauthier C, Farabollini A, et al. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007; 28 (13): 2233–43CrossRef Bravo-Osuna I, Vauthier C, Farabollini A, et al. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007; 28 (13): 2233–43CrossRef
23.
Zurück zum Zitat Bernkop-Schnurch A, Guggi D, Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 2004; 94 (1): 177–86CrossRef Bernkop-Schnurch A, Guggi D, Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 2004; 94 (1): 177–86CrossRef
24.
Zurück zum Zitat Bernkop-Schnurch A, Kast CE. Chemically modified chitosans as enzyme inhibitors. Adv Drug Deliv Rev 2001; 52 (2): 127–37CrossRef Bernkop-Schnurch A, Kast CE. Chemically modified chitosans as enzyme inhibitors. Adv Drug Deliv Rev 2001; 52 (2): 127–37CrossRef
25.
Zurück zum Zitat Stoy PJ. The use of topical application in the treatment of inflammatory conditions of the oral mucosa. Dent Practice 1966; 16: 444–7 Stoy PJ. The use of topical application in the treatment of inflammatory conditions of the oral mucosa. Dent Practice 1966; 16: 444–7
26.
Zurück zum Zitat Browne RM, Fox EC, Anderson RJ. Topical triamcinolone in recurrent aphthous stomatitis. Lancet 1968; 16: 565–7CrossRef Browne RM, Fox EC, Anderson RJ. Topical triamcinolone in recurrent aphthous stomatitis. Lancet 1968; 16: 565–7CrossRef
27.
Zurück zum Zitat Dale RA, Berrong JM, Sandoval VA, et al. The use of ORA 5 on recurrent aphthous ulcers. Gen Dent 1989; Nov–Dec: 504–7 Dale RA, Berrong JM, Sandoval VA, et al. The use of ORA 5 on recurrent aphthous ulcers. Gen Dent 1989; Nov–Dec: 504–7
28.
Zurück zum Zitat Natah SS, Konttinen YT, Enattah NS, et al. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 2004; 33 (3): 221–34CrossRef Natah SS, Konttinen YT, Enattah NS, et al. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 2004; 33 (3): 221–34CrossRef
Metadaten
Titel
Efficacy of a Mucoadhesive Patch Compared with an Oral Solution for Treatment of Aphthous Stomatitis
verfasst von
Avner Shemer
Boaz Amichai
Henri Trau
Nir Nathansohn
Boaz Mizrahi
Prof. Abraham J. Domb
Publikationsdatum
01.01.2008
Verlag
Springer International Publishing
Erschienen in
Drugs in R&D / Ausgabe 1/2008
Print ISSN: 1174-5886
Elektronische ISSN: 1179-6901
DOI
https://doi.org/10.2165/00126839-200809010-00003